Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study
- PMID: 19211227
- DOI: 10.1016/j.pscychresns.2008.04.003
Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study
Abstract
Blood-brain barrier (BBB) dysfunction may contribute to the risk of Alzheimer's disease (AD). Dynamic contrast-enhanced magnetic resonance imaging (MRI) was performed repeatedly nine times before and up to 30 min following a 20 ml Gd-DTPA bolus injection in 15 AD participants and 15 healthy older people. For each participant, small circular regions of interest (size: 9 voxels) were placed to sample widely the deep gray matter (12 regions), cortical gray matter (72 regions), white matter (72 regions) and CSF (8 regions) as well as the basilar and internal carotid arteries (3 regions). Data were analysed using mixed effects models. There was no overall significant difference for AD subjects versus controls, but there was a significant effect for the time-by-AD interaction. Estimated marginal means remained essentially unchanged in AD subjects, but increased slowly after 15 min in healthy controls. An initial rise in gray matter MRI signal intensity followed by a later increase was also seen in AD participants after adjusting for CSF MRI signal intensities. The data suggest that BBB permeability is present even at an early stage of AD. Though the extent of leakage was no greater than that of non-demented people of a similar age in this small sample, the temporal pattern differed, indicating different blood-brain-CSF compartmental kinetics.
Similar articles
-
Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: diagnosis and gender effects.Neuroimage. 2004 Sep;23(1):325-35. doi: 10.1016/j.neuroimage.2004.04.026. Neuroimage. 2004. PMID: 15325380
-
In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease.Neuroimage. 2001 Aug;14(2):298-309. doi: 10.1006/nimg.2001.0848. Neuroimage. 2001. PMID: 11467904
-
Verbal episodic memory impairment in Alzheimer's disease: a combined structural and functional MRI study.Neuroimage. 2005 Mar;25(1):253-66. doi: 10.1016/j.neuroimage.2004.10.045. Epub 2004 Dec 10. Neuroimage. 2005. PMID: 15734360
-
Application of multimodal MR imaging on studying Alzheimer's disease: a survey.Curr Alzheimer Res. 2013 Oct;10(8):877-92. doi: 10.2174/15672050113109990150. Curr Alzheimer Res. 2013. PMID: 23919775 Review.
-
Magnetic resonance imaging in dementia. A study of brain white matter changes.Acta Radiol Suppl. 2002 Jul;(428):1-32. doi: 10.1034/j.1600-0455.43.s.428.1.x. Acta Radiol Suppl. 2002. PMID: 12145969 Review.
Cited by
-
[Alzheimer Dementia and Microvascular Pathology: Blood-Brain Barrier Permeability Imaging].Taehan Yongsang Uihakhoe Chi. 2020 May;81(3):488-500. doi: 10.3348/jksr.2020.81.3.488. Epub 2020 May 29. Taehan Yongsang Uihakhoe Chi. 2020. PMID: 36238621 Free PMC article. Review. Korean.
-
The impact of manganese on vascular endothelium.Toxicol Res. 2024 Aug 13;40(4):501-517. doi: 10.1007/s43188-024-00260-1. eCollection 2024 Oct. Toxicol Res. 2024. PMID: 39345740 Free PMC article. Review.
-
Blood-Brain Barrier: From Physiology to Disease and Back.Physiol Rev. 2019 Jan 1;99(1):21-78. doi: 10.1152/physrev.00050.2017. Physiol Rev. 2019. PMID: 30280653 Free PMC article. Review.
-
Aberrant Cerebral Iron Trafficking Co-morbid With Chronic Inflammation: Molecular Mechanisms and Pharmacologic Intervention.Front Neurol. 2022 Mar 15;13:855751. doi: 10.3389/fneur.2022.855751. eCollection 2022. Front Neurol. 2022. PMID: 35370907 Free PMC article. Review.
-
Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood-brain barrier.Front Drug Deliv. 2023;3:1227816. doi: 10.3389/fddev.2023.1227816. Epub 2023 Jul 10. Front Drug Deliv. 2023. PMID: 37583474 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
